News Conference News ACC 2026 SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients Michael O'Riordan March 30, 2026
News Conference News ACC 2026 PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV Michael O'Riordan March 29, 2026
News Conference News ACC 2026 KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension Caitlin E. Cox March 28, 2026
News Daily News No Major Progress on Making CV Care More Affordable: JACC Stats Todd Neale March 18, 2026
News Daily News Digital Data May Sway Intensive BP Treatment in the Elderly L.A. McKeown March 09, 2026
News Daily News Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone Michael O'Riordan March 03, 2026
News Daily News Four in Five US Adults With Hypertension Have Uncontrolled BP Todd Neale February 03, 2026
News Daily News Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment Yael L. Maxwell January 21, 2026
News Daily News Weight Regained Within 18 Months of Stopping GLP-1 Drugs Michael O'Riordan January 08, 2026
News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Daily News AHA Highlights Single-Pill Combo Therapy for Hypertension Todd Neale December 17, 2025
News Daily News Aprocitentan Effective in CKD Patients With Resistant Hypertension: PRECISION Todd Neale December 16, 2025